Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Income from Continuing Operations of 32812488.33 for Q1 2026, up 17.65% year-over-year from 27889664.03 in Q1 2025, and down 40.78% quarter-over-quarter from 55408471.3 in Q4 2025.

Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Income from Continuing Operations for 7 consecutive years, with 32812488.33 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 17.65% year-over-year to 32812488.33; the TTM figure through Mar 2026 stood at 163966765.82 (up 21.72% YoY), while the FY2025 annual figure was 162733283.35, up 29.28% from the prior year.
  • Income from Continuing Operations eased to 32812488.33 in Q1 2026 per STVN's latest filing, from 55408471.3 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 55408471.3 in Q4 2025 and bottomed at 20436637.56 in Q1 2024.
  • Historically, Income from Continuing Operations has averaged 36845925.67 across 5 years, with a median of 33628258.41 in 2025.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 66.8% — and 2024, when it plunged 40.42%.
  • Stevanato Group S.p.A's Income from Continuing Operations stood at 49277947.74 in 2022, then retreated by 1.31% to 48632483.89 in 2023, then rose by 6.13% to 51613157.83 in 2024, then advanced by 7.35% to 55408471.3 in 2025, then plunged by 40.78% to 32812488.33 in 2026.
  • Business Quant data shows STVN's Income from Continuing Operations at 32812488.33 in Q1 2026, 55408471.3 in Q4 2025, and 42117547.78 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 452.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 135.00 Mn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn 26.68 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 26.68 Mn
Mar 31, 2026 32.81 Mn
Dec 31, 2025 55.41 Mn
Sep 30, 2025 42.12 Mn
Jun 30, 2025 33.63 Mn
Mar 31, 2025 27.89 Mn
Dec 31, 2024 51.61 Mn
Sep 30, 2024 32.95 Mn
Jun 30, 2024 22.26 Mn
Mar 31, 2024 20.44 Mn
Dec 31, 2023 48.63 Mn
Sep 30, 2023 41.25 Mn
Jun 30, 2023 37.36 Mn
Mar 31, 2023 30.32 Mn
Dec 31, 2022 49.28 Mn
Sep 30, 2022 36.59 Mn
Jun 30, 2022 32.68 Mn
Mar 31, 2022 31.16 Mn
Dec 31, 2021 51.02 Mn
Sep 30, 2021 21.93 Mn